Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 15, 2023Frontiers in Cardiovascular MedicineOpen Access

Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals

View Full Paper
Ask AI
Bookmark
Share

Key result

A multidisciplinary cardio-oncology roadmap is proposed to provide personalized cardiovascular care, monitoring, and rehabilitation for cancer survivors throughout their lifespan.

Why the study?

The growing population of cancer survivors faces risks of late-onset cancer therapy-related cardiovascular toxicity, but current healthcare systems often provide fragmented management instead of personalized, multidisciplinary care.

Does a multidisciplinary cardio-oncology survivorship care plan improve the management of cancer therapy-related cardiovascular toxicity in cancer survivors?

Population

Cancer survivors, including those cured and free from cancer at risk of late-onset cancer therapy-related…

Comparison

Multidisciplinary-guided survivorship care plan… vs Fragmented management of current healthcare…

Design

Review

Authors

IBIrma BiscegliaMCMaria Laura CanaleNSNicola Silvestris

Discussion

Loading...

Member takes

Overview

Proposed roadmap supports integrated cardio-oncology care for survivors; leaves open whether implementation improves outcomes.

Structured PICO

Does a multidisciplinary cardio-oncology survivorship care plan improve the management of cancer therapy-related cardiovascular toxicity in cancer survivors?

P
Population
Cancer survivors, including those cured and free from cancer at risk of late-onset cancer therapy-related cardiovascular toxicity (CTR-CVT), and those with long-term control of not-curable cancers.
I
Intervention
Multidisciplinary-guided survivorship care plan involving collaboration between oncologists, cardiologists, primary care providers, and other specialists.
C
Comparator
Fragmented management of current healthcare systems.
O
Outcome
Personalized care of cancer survivors and management of cancer therapy-related cardiovascular toxicity.

A multidisciplinary cardio-oncology approach is essential for the personalized care and management of cardiovascular toxicity in the growing population of cancer survivors.

Limitations

  • Lifelong monitoring of all survivors is not feasible due to unaffordable costs
  • Fragmentation of healthcare systems and lack of compliance by cancer survivors hinder survivorship care plans

Cite This Study

Bisceglia et al. (2023) conducted a review in Cancer survivorship and cardiovascular disease. Multidisciplinary cardio-oncology care was evaluated. A multidisciplinary cardio-oncology roadmap is proposed to provide personalized cardiovascular care, monitoring, and rehabilitation for cancer survivors throughout their lifespan.

synapsesocial.com/papers/6a6b8b5f01245da06ecb823ehttps://doi.org/10.3389/fcvm.2023.1223660
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of cardiovascular magnetic resonance imaging in cardio-oncology2020 · 54 citations
  2. 2ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO)2021 · 8 citations
  3. 3Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries2021 · 114,748 citations
  4. 4Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer2019 · 102 citations
  5. 5Long‐Term Outcomes of Patients With Mediastinal Radiation–Associated Severe Aortic Stenosis and Subsequent Surgical Aortic Valve Replacement: A Matched Cohort Study2017 · 105 citations